Su-Varn2a

A blog focused on technology in medicine is maintained.

About Su-Varn2a

Su-Varn2a is a Healthcare company. A blog focused on technology in medicine is maintained. It operates on a HealthTech model. The company has 185 employees. Su-Varn2a has completed 1 acquisition, including Medprecinct. Its Indian entity Suvarna Technosoft Private Limited reported revenue of β‚Ή27.67 Cr. Su-Varn2a offers products and services including Medical Information Systems and Telemedicine Solutions. Its focus areas include Medical Technology and Health IT Solutions.

Company details

Content related to the latest technologies in medicine is shared through a dedicated blog. Innovations in medical diagnostics, telemedicine, and healthcare IT systems are explored. The role of engineering and software in optimizing medical resources is highlighted. Contributions to the healthcare sector through insights and discussions are provided.

Key Metrics
  • Indian entity revenue
    ₹27.67 Cr

    FY 2025 · +1% YoY

  • Indian entity net profit
    ₹1.03 Cr

    FY 2025 · 4% margin

  • Indian entity EBITDA
    ₹4.15 Cr

    FY 2025 · 15% margin

  • Employee Count
    185
  • Investments & Acquisitions

Products & Services of Su-Varn2a

Su-Varn2a offers a comprehensive portfolio of products and services, including Medical Information Systems and Telemedicine Solutions.

Medical Information Systems
Healthcare IT

Systems for managing medical data are developed and implemented.

Telemedicine Solutions
Healthcare Technology

Remote medical consultations are facilitated through digital platforms.

Board of directors of Suvarna Technosoft Private Limited (Su-Varn2a)

Suvarna Technosoft Private Limited is the primary company behind Su-Varn2a. The board of Suvarna Technosoft Private Limited currently have 2 directors; the longest-serving is Veena Tarigopula, appointed in 2003.

DirectorDesignationAppointedTenureEntity
Veena Tarigopula
DIN 02880166
Director13 Jun 200323 yrs 4 moSuvarna Technosoft Private Limited
Samba Sivasuresh Tarigopula
DIN 01817951
Director13 Jun 200323 yrs 4 moSuvarna Technosoft Private Limited

Financials of Su-Varn2a

Figures of Suvarna Technosoft Private Limited, the primary company behind Su-Varn2a, for FY 2025. Revenue was ₹27.67 Cr (+1% year on year). Net profit was ₹1.03 Cr (4% margin). EBITDA was ₹4.15 Cr (15% margin). Revenue has grown at a compounded annual rate of +9% over three years and +12% over five years.

  • ₹27.67 CrRevenue · FY 2025 · +1% YoY
  • ₹1.03 CrNet profit · 4% margin
  • ₹4.15 CrEBITDA · 15% margin
  • ₹53.5 LakhPaid-up capital
  • 185Employees (provident fund records)
  • +9%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Suvarna Technosoft Private Limited are on its company page.

Premium access

Detailed financial statements for Su-Varn2a

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Su-Varn2a

Su-Varn2a has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medprecinct.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Business development services are provided for the biopharma sector.
medprecinct.comNavi Mumbai, India2016Apr 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for Su-Varn2a

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Su-Varn2a

Premium access

Complete news archive for Su-Varn2a

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Su-Varn2a

Su-Varn2a has 185 employees.

The primary company behind Su-Varn2a, Suvarna Technosoft Private Limited, reported revenue of β‚Ή27.67 Cr for FY 2025, up 1% year on year.

Content related to the latest technologies in medicine is shared through a dedicated blog. Innovations in medical diagnostics, telemedicine, and healthcare IT systems are explored. The role of engineering and software in optimizing medical resources is highlighted. Contributions to the healthcare sector through insights and discussions are provided.

Su-Varn2a offers Medical Information Systems and Telemedicine Solutions.

Su-Varn2a has made 1 acquisition, including Medprecinct.

Su-Varn2a operates through Suvarna Technosoft Private Limited.

The legal entities of Su-Varn2a currently have 2 directors, including Veena Tarigopula, Samba Sivasuresh Tarigopula.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available